Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kevin Poole

Physician Assistant Pleasant Prairie, WI Physician Assistant

NPI 1477529915 CMS profile 10590332

12500 Aurora Dr, Pleasant Prairie, WI 53158

Open in the dashboard

General payments

$1,121

53 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Poole of Pleasant Prairie, WI is reported in the CMS Open Payments database as having received $1,121 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16 1
2023 General $371 10
2022 General $390 18
2021 General $344 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Poole
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kevin Poole were reported at $16. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kevin Poole Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $344 $132 $37–$438 $132
2022 $390 $155 $48–$522 $149
2023 $371 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $16 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Organogenesis Inc. $402 11 payments
  2. Radius Health, Inc. $375 18 payments
  3. Flexion Therapeutics, Inc. $344 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,121 53 payments
Products named General payments · program years 2021–2025
  1. Puraply $386 10 payments
  2. Zilretta $344 24 payments
  3. Tymlos Endocrinology $155 7 payments
  4. Tymlos Endocrinology $16 1 payment
  5. CYGNUS DUAL $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

699

Median for Physician Assistant: 241

Drug cost

$5,753

Median for Physician Assistant: $4,110

Branded share of claims

40.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 257 $2,876
Doxycycline Hyclate Generic 100 $972
Ondansetron Hcl Generic 113 $595
Tizanidine Hcl Generic 82 $489
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 26 $292
Cyclobenzaprine Hcl Generic 43 $225
Oxycodone Hcl Generic 22 $135
Tramadol Hcl Generic 28 $107
Meloxicam Generic 13 $46
Lorazepam Generic 15 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$32,726

Of which drugs: $11,700

Medicare patients

157

Average age 75

Services billed

5,792

100 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 29%
Chronic kidney disease 27%
Ischemic heart disease 25%
Atrial fibrillation 24%
Depression 24%
Heart failure 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 19 1,408 $9,730
Injection, methylprednisolone acetate, 1 mg J1010 Office 34 3,920 $366
Injection, methylprednisolone acetate, 80 mg J1040 Office 14 14 $46

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record